Novo Biosciences
Bar Harbor
About Novo Biosciences
Novo Biosciences develops cardiac drugs designed to reverse the life-threatening damage caused by heart attacks. Its drugs spur the body to heal itself by triggering powerful mechanisms of self-repair and regrowth that lie dormant in genes, enabling patients to regenerate damaged organs and tissues and live a healthier life. The company was founded in 2013 and is headquartered in Bar Harbor, Maine.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.6M
- Last round: Series Unknown (May 2020)
- Website: novobiosciences.com
Industries & Categories
Biotechnology, Health Care, Medical, Wellness
Canonical: https://fsome.com/organization/novo-biosciences-125720 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.